Asymmetric Unit(hide GO term definitions)
Chain C,D ( HS71A_HUMAN | P0DMV8)
molecular function |
| GO:0005524 | | ATP binding | | Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| GO:0016887 | | ATPase activity | | Catalysis of the reaction: ATP + H2O = ADP + phosphate + 2 H+. May or may not be coupled to another reaction. |
| GO:0042623 | | ATPase activity, coupled | | Catalysis of the reaction: ATP + H2O = ADP + phosphate; this reaction directly drives some other reaction, for example ion transport across a membrane. |
| GO:0055131 | | C3HC4-type RING finger domain binding | | Interacting selectively and non-covalently with a C3HC4-type zinc finger domain of a protein. The C3HC4-type zinc finger is a variant of RING finger, is a cysteine-rich domain of 40 to 60 residues that coordinates two zinc ions, and has the consensus sequence: C-X2-C-X(9-39)-C-X(1-3)-H-X(2-3)-C-X2-C-X(4-48)-C-X2-C, where X is any amino acid. Many proteins containing a C3HC4-type RING finger play a key role in the ubiquitination pathway. |
| GO:0001664 | | G-protein coupled receptor binding | | Interacting selectively and non-covalently with a G-protein coupled receptor. |
| GO:0019899 | | enzyme binding | | Interacting selectively and non-covalently with any enzyme. |
| GO:0031072 | | heat shock protein binding | | Interacting selectively and non-covalently with a heat shock protein, any protein synthesized or activated in response to heat shock. |
| GO:0042826 | | histone deacetylase binding | | Interacting selectively and non-covalently with the enzyme histone deacetylase. |
| GO:0000166 | | nucleotide binding | | Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0044183 | | protein binding involved in protein folding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules) that contributes to the process of protein folding. |
| GO:0005102 | | receptor binding | | Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
| GO:0031625 | | ubiquitin protein ligase binding | | Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins. |
| GO:0051082 | | unfolded protein binding | | Interacting selectively and non-covalently with an unfolded protein. |
| GO:0001618 | | virus receptor activity | | Combining with a virus component and mediating entry of the virus into the cell. |
biological process |
| GO:0046034 | | ATP metabolic process | | The chemical reactions and pathways involving ATP, adenosine triphosphate, a universally important coenzyme and enzyme regulator. |
| GO:0006281 | | DNA repair | | The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway. |
| GO:0070370 | | cellular heat acclimation | | Any process that increases heat tolerance of a cell in response to high temperatures. |
| GO:0034605 | | cellular response to heat | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism. |
| GO:0034599 | | cellular response to oxidative stress | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals. |
| GO:0060548 | | negative regulation of cell death | | Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. |
| GO:1902236 | | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | | Any process that stops, prevents or reduces the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway. |
| GO:2001240 | | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand. |
| GO:0090084 | | negative regulation of inclusion body assembly | | Any process that decreases the rate, frequency, or extent of inclusion body assembly. Inclusion body assembly is the aggregation, arrangement and bonding together of a set of components to form an inclusion body. |
| GO:1901029 | | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | | Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway. |
| GO:0031397 | | negative regulation of protein ubiquitination | | Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of ubiquitin groups to a protein. |
| GO:0051092 | | positive regulation of NF-kappaB transcription factor activity | | Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB. |
| GO:1902380 | | positive regulation of endoribonuclease activity | | Any process that activates or increases the frequency, rate or extent of endoribonuclease activity. |
| GO:0010628 | | positive regulation of gene expression | | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| GO:0032757 | | positive regulation of interleukin-8 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-8 production. |
| GO:1904722 | | positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response | | Any process that activates or increases the frequency, rate or extent of mRNA endonucleolytic cleavage involved in unfolded protein response. |
| GO:0070434 | | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | | Any process that activates or increases the frequency, rate, or extent of the nucleotide-binding oligomerization domain containing 2 (NOD2) pathway. |
| GO:1903265 | | positive regulation of tumor necrosis factor-mediated signaling pathway | | Any process that activates or increases the frequency, rate or extent of tumor necrosis factor-mediated signaling pathway. |
| GO:0042026 | | protein refolding | | The process carried out by a cell that restores the biological activity of an unfolded or misfolded protein, using helper proteins such as chaperones. |
| GO:0050821 | | protein stabilization | | Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation. |
| GO:0010941 | | regulation of cell death | | Any process that modulates the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. |
| GO:1900034 | | regulation of cellular response to heat | | Any process that modulates the frequency, rate or extent of cellular response to heat. |
| GO:0043488 | | regulation of mRNA stability | | Any process that modulates the propensity of mRNA molecules to degradation. Includes processes that both stabilize and destabilize mRNAs. |
| GO:0031396 | | regulation of protein ubiquitination | | Any process that modulates the frequency, rate or extent of the addition of ubiquitin groups to a protein. |
| GO:0009408 | | response to heat | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism. |
| GO:0000723 | | telomere maintenance | | Any process that contributes to the maintenance of proper telomeric length and structure by affecting and monitoring the activity of telomeric proteins, the length of telomeric DNA and the replication and repair of the DNA. These processes includes those that shorten, lengthen, replicate and repair the telomeric DNA sequences. |
| GO:0046718 | | viral entry into host cell | | The process that occurs after viral attachment by which a virus, or viral nucleic acid, breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the viral nucleic acid is released into the host cell cytoplasm. |
cellular component |
| GO:0072562 | | blood microparticle | | A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids. |
| GO:0005814 | | centriole | | A cellular organelle, found close to the nucleus in many eukaryotic cells, consisting of a small cylinder with microtubular walls, 300-500 nm long and 150-250 nm in diameter. It contains nine short, parallel, peripheral microtubular fibrils, each fibril consisting of one complete microtubule fused to two incomplete microtubules. Cells usually have two centrioles, lying at right angles to each other. At division, each pair of centrioles generates another pair and the twin pairs form the pole of the mitotic spindle. |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| GO:0005925 | | focal adhesion | | Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. |
| GO:0016234 | | inclusion body | | A discrete intracellular part formed of aggregated molecules such as proteins or other biopolymers. |
| GO:0005739 | | mitochondrion | | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
| GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| GO:0048471 | | perinuclear region of cytoplasm | | Cytoplasm situated near, or occurring around, the nucleus. |
| GO:0000151 | | ubiquitin ligase complex | | A protein complex that includes a ubiquitin-protein ligase and enables ubiquitin protein ligase activity. The complex also contains other proteins that may confer substrate specificity on the complex. |
Chain C,D ( HS71B_HUMAN | P0DMV9)
molecular function |
| GO:0005524 | | ATP binding | | Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| GO:0016887 | | ATPase activity | | Catalysis of the reaction: ATP + H2O = ADP + phosphate + 2 H+. May or may not be coupled to another reaction. |
| GO:0042623 | | ATPase activity, coupled | | Catalysis of the reaction: ATP + H2O = ADP + phosphate; this reaction directly drives some other reaction, for example ion transport across a membrane. |
| GO:0055131 | | C3HC4-type RING finger domain binding | | Interacting selectively and non-covalently with a C3HC4-type zinc finger domain of a protein. The C3HC4-type zinc finger is a variant of RING finger, is a cysteine-rich domain of 40 to 60 residues that coordinates two zinc ions, and has the consensus sequence: C-X2-C-X(9-39)-C-X(1-3)-H-X(2-3)-C-X2-C-X(4-48)-C-X2-C, where X is any amino acid. Many proteins containing a C3HC4-type RING finger play a key role in the ubiquitination pathway. |
| GO:0001664 | | G-protein coupled receptor binding | | Interacting selectively and non-covalently with a G-protein coupled receptor. |
| GO:0019899 | | enzyme binding | | Interacting selectively and non-covalently with any enzyme. |
| GO:0031072 | | heat shock protein binding | | Interacting selectively and non-covalently with a heat shock protein, any protein synthesized or activated in response to heat shock. |
| GO:0042826 | | histone deacetylase binding | | Interacting selectively and non-covalently with the enzyme histone deacetylase. |
| GO:0000166 | | nucleotide binding | | Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0044183 | | protein binding involved in protein folding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules) that contributes to the process of protein folding. |
| GO:0005102 | | receptor binding | | Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
| GO:0031625 | | ubiquitin protein ligase binding | | Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins. |
| GO:0051082 | | unfolded protein binding | | Interacting selectively and non-covalently with an unfolded protein. |
| GO:0001618 | | virus receptor activity | | Combining with a virus component and mediating entry of the virus into the cell. |
biological process |
| GO:0046034 | | ATP metabolic process | | The chemical reactions and pathways involving ATP, adenosine triphosphate, a universally important coenzyme and enzyme regulator. |
| GO:0070370 | | cellular heat acclimation | | Any process that increases heat tolerance of a cell in response to high temperatures. |
| GO:0034605 | | cellular response to heat | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism. |
| GO:0034599 | | cellular response to oxidative stress | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals. |
| GO:0060548 | | negative regulation of cell death | | Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. |
| GO:2001240 | | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand. |
| GO:0090084 | | negative regulation of inclusion body assembly | | Any process that decreases the rate, frequency, or extent of inclusion body assembly. Inclusion body assembly is the aggregation, arrangement and bonding together of a set of components to form an inclusion body. |
| GO:0031397 | | negative regulation of protein ubiquitination | | Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of ubiquitin groups to a protein. |
| GO:0051092 | | positive regulation of NF-kappaB transcription factor activity | | Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB. |
| GO:0010628 | | positive regulation of gene expression | | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| GO:0032757 | | positive regulation of interleukin-8 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-8 production. |
| GO:0070434 | | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | | Any process that activates or increases the frequency, rate, or extent of the nucleotide-binding oligomerization domain containing 2 (NOD2) pathway. |
| GO:1903265 | | positive regulation of tumor necrosis factor-mediated signaling pathway | | Any process that activates or increases the frequency, rate or extent of tumor necrosis factor-mediated signaling pathway. |
| GO:0042026 | | protein refolding | | The process carried out by a cell that restores the biological activity of an unfolded or misfolded protein, using helper proteins such as chaperones. |
| GO:0050821 | | protein stabilization | | Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation. |
| GO:0010941 | | regulation of cell death | | Any process that modulates the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. |
| GO:1900034 | | regulation of cellular response to heat | | Any process that modulates the frequency, rate or extent of cellular response to heat. |
| GO:0031396 | | regulation of protein ubiquitination | | Any process that modulates the frequency, rate or extent of the addition of ubiquitin groups to a protein. |
| GO:0046718 | | viral entry into host cell | | The process that occurs after viral attachment by which a virus, or viral nucleic acid, breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the viral nucleic acid is released into the host cell cytoplasm. |
cellular component |
| GO:0072562 | | blood microparticle | | A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids. |
| GO:0005814 | | centriole | | A cellular organelle, found close to the nucleus in many eukaryotic cells, consisting of a small cylinder with microtubular walls, 300-500 nm long and 150-250 nm in diameter. It contains nine short, parallel, peripheral microtubular fibrils, each fibril consisting of one complete microtubule fused to two incomplete microtubules. Cells usually have two centrioles, lying at right angles to each other. At division, each pair of centrioles generates another pair and the twin pairs form the pole of the mitotic spindle. |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| GO:0005925 | | focal adhesion | | Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. |
| GO:0016234 | | inclusion body | | A discrete intracellular part formed of aggregated molecules such as proteins or other biopolymers. |
| GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| GO:0048471 | | perinuclear region of cytoplasm | | Cytoplasm situated near, or occurring around, the nucleus. |
| GO:0000151 | | ubiquitin ligase complex | | A protein complex that includes a ubiquitin-protein ligase and enables ubiquitin protein ligase activity. The complex also contains other proteins that may confer substrate specificity on the complex. |
|